People with ulcerative colitis are susceptible to an infection from a bacterium called Clostridioides difficile, or C. diff. Here’s what to do if you think you have it.

University of Wisconsin–Madison–led researchers report lower yet statistically non-significant recurrence of Clostridioides difficile (C. diff) among adults given low-dose oral vancomycin ...

Here are the C. diff infection rates of PPS-exempt cancer hospitals between July 7, 2023, and June 30, 2024, according to CMS data: University of Texas MD Anderson Cancer Center (Houston): 0.237 ...

The Vera C. Rubin Observatory has released its first images, providing a staggering glimpse at the observing power it will unleash when it begins its decade-long survey.

Fecal microbiota transplant was noninferior to vancomycin as the initial treatment for C. diff in a randomized, open-label trial. Transplant showed slightly higher cure rates without recurrence ...

Study finds traditional fecal transplant outperforms new pill in severe C. diff. cases by Kendall Daniels Rovinsky, University of North Carolina at Chapel Hill School of Medicine ...

In this edition of The People’s Pharmacy, Joe and Teresa Graedon also hear from a reader with a solution for itchy insect bites.

One of the most common health care-associated infections spreads within intensive care units (ICUs) more than three times more than previously thought, new research has found.

Research has found that C. difficile, one of the most common and contagious hospital-acquired infections, spreads more than three times more than previously thought, moving covertly from surface to ...

The pathogen C. diff -- the most common cause of health care-associated infectious diarrhea -- can use a compound that kills the human gut's resident microbes to survive and grow, giving it a ...